Critical

Refractory status epilepticus (ICU)

status epilepticus · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Status epilepticus that continues despite adequate benzodiazepine and a second-line antiseizure medication is refractory and requires intubation and anaesthetic (third-line) infusions titrated to seizure control or burst suppression. Super-refractory status persists beyond 24 h of anaesthesia and needs aggressive investigation for the underlying cause.

Red flags

  • Ongoing electrographic seizures despite two agents
  • Falling conscious level without motor signs (non-convulsive status)
  • Hyperthermia and rhabdomyolysis
  • Hypotension from anaesthetic infusions
  • Metabolic acidosis on high-dose propofol (PRIS)

Assessment

Differential diagnosis

  • CNS infection (encephalitis/meningitis)
  • Acute structural lesion (stroke, haemorrhage, tumour)
  • Autoimmune encephalitis
  • Metabolic derangement (sodium, glucose, calcium)
  • Drug toxicity / withdrawal
  • Anoxic brain injury
  • Non-convulsive status

Investigations

  • Capillary and lab glucose, sodium, calcium, magnesium
  • Continuous EEG monitoring
  • CT/MRI brain
  • Lumbar puncture (CNS infection/autoimmune)
  • Antiseizure drug levels and toxicology
  • Autoimmune and paraneoplastic antibodies

Management

  • Confirm ongoing seizures (clinical or electrographic) and secure airway, breathing and circulation
  • Check and correct glucose, sodium, calcium and magnesium immediately
  • First-line: a benzodiazepine at an adequate dose (lorazepam IV, or IM midazolam if no access)
  • Second-line (urgent control) antiseizure medication: levetiracetam, or sodium valproate, or phenytoin/fosphenytoin at full loading dose
  • If seizures continue, declare refractory status, intubate and start a third-line anaesthetic infusion (midazolam, propofol or thiopentone)
  • Titrate the anaesthetic to seizure cessation, then to electrographic burst suppression on continuous EEG for 24-48 h
  • Continue maintenance antiseizure medications alongside the anaesthetic
  • Investigate and treat the cause aggressively (empirical aciclovir and antibiotics if CNS infection possible; immunotherapy if autoimmune suspected)
  • Maintain haemodynamics and watch for propofol infusion syndrome with high-dose propofol
  • Wean the anaesthetic slowly after 24-48 h of control and watch for seizure recurrence on EEG
  • For super-refractory status escalate therapies (ketamine, additional agents, immunotherapy, ketogenic diet) with neurology
  • Avoid and correct hyperthermia and metabolic complications

Drugs & doses

Lorazepam 0.1 mg/kg IV (max 4 mg/dose, may repeat once)
Midazolam 10 mg IM if no IV access
Levetiracetam 60 mg/kg IV (max 4.5 g)
Sodium valproate 40 mg/kg IV (max 3 g)
Fosphenytoin 20 mg PE/kg IV
Midazolam infusion 0.05-2 mg/kg/h IV
Propofol infusion 1-5 mg/kg/h IV (watch PRIS)
Thiopentone 3-5 mg/kg load then 1-5 mg/kg/h IV
Ketamine infusion for super-refractory cases

Disposition

ICU with continuous EEG and neurology input; consider transfer to a neurocritical care centre for super-refractory status.

Complications & pitfalls

  • Neuronal injury and cognitive sequelae
  • Aspiration and respiratory failure
  • Propofol infusion syndrome
  • Haemodynamic instability
  • Rhabdomyolysis and AKI
  • Death

Exam pearls

  • Underdosing benzodiazepines is the commonest early error - give the full weight-based dose
  • Any unexplained coma after convulsions warrants continuous EEG to exclude non-convulsive status
  • Target burst suppression and maintain for 24-48 h before weaning the anaesthetic
  • Hunt relentlessly for the cause in super-refractory status, including autoimmune encephalitis

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.